Verona, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LUPUS AND ALLIED DISEASES ASSOCIATION INC, founded in 1978, is a small nonprofit that reported $987K in total revenue in fiscal year 2024. Revenue decreased 8% compared to the prior year. The organization ran a surplus of $247K, a strong 25% operating margin.
The Lupus and Allied Diseases Association's mission is to advocate for those affected by lupus and allied diseases through public awareness, education and research program initiatives to improve quality of life.
1. The organization supported lupus research to improve methods of diagnosis and treatment by funding a $150,000 grant to the the Lupus Research Alliance to support SLE Cognitive Impairment...
1. The organization supported lupus research to improve methods of diagnosis and treatment by funding a $150,000 grant to the the Lupus Research Alliance to support SLE Cognitive Impairment Differentiation and Imaging Lupus Nephritis Biopsies Prognosis Projects. 2. The organization supported pediatric lupus research to study Advancing Molecular Profiling and Understanding Adverse Events Projects in the pediatric population by funding a $89,424 grant to the Childhood Arthritis and Rheumatology Research Alliance. 3. The organization also supported $25,000 to support Does Air Pollution Influence the Baseline Characteristics of Pediatric SLE Project to improve the quality of life for the pediatric population with lupus at the Lupus Foundation of America. 4. The organization funded the Marc R. Chevrier, MD, PhD, FACR, Lupus Research Memorial Fund at the Rheumatology Research Foundation by supporting a $25,300 preceptorship grant and a separate $50,000 grant to support Innovative Lupus Research. 5. The organization supported lupus research by funding a $200,000 grant to the Masonic Medical Research Institute to provide $50,000 to support a study on Gain-of-function mutations in SHP2 enhance inflammatory macrophage activation in SLE, $50,000 for Cell Activation in Venous Thromboembolism in Female Murine SLE, $50,000 for pathophysiological role of IRF2BP2 in SLE, and $50,000 for Identification of Novel Genes in Lupus Nephritis Development.
The organization provided public education and advocated for those impacted by lupus and autoimmune diseases in various states and federally through education meetings, briefings, seminars, forums...
The organization provided public education and advocated for those impacted by lupus and autoimmune diseases in various states and federally through education meetings, briefings, seminars, forums, public testimony, and written comments. The organization also distributed informational materials, newsletters, and issue briefs; developed poster presentations; and represented the lupus and autoimmune patient perspective at education and advocacy initiatives to improve access to medical care and treatments and advance biomedical research to improve patient quality of life. The organization also provided a $25,000 education grant to the Masonic Medical Research Institute to support their general education program and Summer Fellows education program.
The organization promoted disease awareness by disseminating information at virtual and in person health and wellness events; participating in media interviews, press releases, speaking engagements...
The organization promoted disease awareness by disseminating information at virtual and in person health and wellness events; participating in media interviews, press releases, speaking engagements and press conferences; posting information and resources to websites and through social media, blogs, op-eds, videos, and e-mails; and hosting informational booths in exhibit halls to improve disease awareness to the general public, medical professional community, public officials, the media, researchers, the healthcare industry, and people with lupus and allied diseases and their loved ones.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $987,432 | $1,076,141 | -0.1% |
| Expenses | $740,149 | $744,720 | 0.0% |
| Net Income | $247,283 | $331,421 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Kathleen A Arntsen | President and CEO | 25 |
Officer
Director
|
$0 | $0 | $0 |
| Lori A Vogel | Treasurer | 15 |
Officer
Director
|
$0 | $0 | $0 |
| David L Arntsen | Secretary | 12 |
Officer
Director
|
$0 | $0 | $0 |
| Sandra M Frear | 1st Vice President | 8 |
Officer
Director
|
$0 | $0 | $0 |
| Anne M Zablotowicz | 2nd Vice President | 14 |
Officer
Director
|
$0 | $0 | $0 |
| Jane M Porter | Director | 8 |
Director
|
$0 | $0 | $0 |
| Jacqueline L Taylor | Director | 4 |
Director
|
$0 | $0 | $0 |
| Dina Thachet | Director | 8 |
Director
|
$0 | $0 | $0 |
| Meghan P Valadez | Director | 4 |
Director
|
$0 | $0 | $0 |
| Brian J Vogel | Director | 4 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $987,432 | $740,149 | $2,825,249 | $247,283 |
| 2024 | $1,076,141 | $744,720 | $2,577,966 | $331,421 |
| 2023 | $1,009,530 | $707,359 | $2,246,545 | $302,171 |
| 2022 | $1,081,866 | $540,739 | $1,944,374 | $541,127 |
| 2021 | $709,022 | $327,832 | $1,403,247 | $381,190 |
| 2020 | $640,821 | $315,807 | $1,022,057 | $325,014 |
Compare LUPUS AND ALLIED DISEASES ASSOCIATION INC with other nonprofits in New York and across the country.